Morgan Stanley
ALHC icon

Morgan Stanley’s Alignment Healthcare ALHC Stock Holding History

Morgan Stanley’s Portfolio ALHC Stock Details ALHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40.5M Buy
1,698,938
+172,099
+11% +$3.3M ﹤0.01% 2446
2026
Q1 		$26.9M Sell
1,526,839
-835,707
-35% -$16.8M ﹤0.01% 2669
2025
Q4 		$46.7M Buy
2,362,546
+384,448
+19% +$6.91M ﹤0.01% 2145
2025
Q3 		$34.5M Buy
1,978,098
+163,424
+9% +$2.42M ﹤0.01% 2349
2025
Q2 		$25.4M Buy
1,814,674
+514,701
+40% +$8.29M ﹤0.01% 2570
2025
Q1 		$24.2M Buy
1,299,973
+539,494
+71% +$8.04M ﹤0.01% 2501
2024
Q4 		$8.56M Buy
760,479
+174,135
+30% +$2.04M ﹤0.01% 3530
2024
Q3 		$6.93M Buy
586,344
+270,108
+85% +$2.55M ﹤0.01% 3703
2024
Q2 		$2.47M Sell
316,236
-49,363
-14% -$322K ﹤0.01% 4414
2024
Q1 		$1.81M Sell
365,599
-354,459
-49% -$2.27M ﹤0.01% 4650
2023
Q4 		$6.2M Buy
720,058
+313,719
+77% +$2.29M ﹤0.01% 3741
2023
Q3 		$2.82M Sell
406,339
-2,118
-0.5% -$12.8K ﹤0.01% 4148
2023
Q2 		$2.35M Sell
408,457
-519,674
-56% -$3.36M ﹤0.01% 4315
2023
Q1 		$5.9M Sell
928,131
-225,253
-20% -$2.15M ﹤0.01% 3643
2022
Q4 		$13.6M Sell
1,153,384
-60,902
-5% -$741K ﹤0.01% 2751
2022
Q3 		$14.4M Buy
1,214,286
+447,120
+58% +$6.52M ﹤0.01% 2571
2022
Q2 		$8.75M Sell
767,166
-319,387
-29% -$3.37M ﹤0.01% 3202
2022
Q1 		$12.2M Sell
1,086,553
-14,413
-1% -$130K ﹤0.01% 2675
2021
Q4 		$15.5M Buy
1,100,966
+127,097
+13% +$2.23M ﹤0.01% 2443
2021
Q3 		$15.6M Buy
973,869
+285,583
+41% +$5.52M ﹤0.01% 2364
2021
Q2 		$16.1M Sell
688,286
-777,923
-53% -$18.9M ﹤0.01% 2404
2021
Q1 		$32.2M Buy
+1,466,209
New +$28.7M ﹤0.01% 1514

Other funds holding ALHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley's ALHC Position: Q2 2026 in Review

Morgan Stanley increased its Alignment Healthcare (ALHC) stake by 11% in Q2 2026, buying an estimated $3.3M and bringing the position to 1,698,938 shares worth $40.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Morgan Stanley first reported a position in ALHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $46.7M in Q4 2025. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Morgan Stanley held 1,698,938 shares of Alignment Healthcare worth $40.5M as of Q2 2026.
  • Morgan Stanley bought 172,099 Alignment Healthcare shares in Q2 2026, an estimated $3.3M.
  • Alignment Healthcare made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #2446 holding.
  • Morgan Stanley first reported a position in Alignment Healthcare in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's Alignment Healthcare position peaked at $46.7M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.